LegalHerald.com reports on the verdicts of three Risperdal lawsuits in which the plaintiffs alleged to have suffered from gynecomastia (male breast growth) as a result of their use of the antipsychotic drug. The complaints were all filed against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, who manufactures the drug.
The first of the three suits awarded the plaintiff and his family $2.5 million. The plaintiff, now 20-years-old, began taking Risperdal when he was 8-years-old to treat symptoms associated with autism. As a teen, he developed size 46DD breasts, a side effect which his suit and many others like it, allege was not disclosed by the manufacturer.
The second suit, which also found favor with the plaintiff, awarded $1.75 million in damages to a Maryland boy and his family for disfigurement and mental anguish after he too developed gynecomastia. This plaintiff was prescribed Risperdal at the age of 9 for the treatment of schizophrenia. The drug was only FDA-approved for adult use at the time. Janssen was found guilty by the Philadelphia jury of failing to warn patients of the risk of developing gynecomastia when taking the drug, despite the fact that the plaintiff continued to take the drug after the 2006 label change and FDA approval for use in children.
The third case found favor with the defendant, Johnson & Johnson (Janssen), due to the fact that a direct link could not be established between the plaintiff’s use of Risperdal and his development of gynecomastia.
The verdicts in favor of the plaintiffs give hope to over 1,600 other individuals who have filed suit against the pharmaceutical company, after suffering from adverse effects that they attribute to their use of the antipsychotic drug.
The attorneys of Banville Law understand how devastating the effects of gynecomastia can be for men. The firm is dedicated to assisting individuals who have used Risperdal and then been diagnosed with the condition and are offering complimentary legal consultations for affected parties. Qualified individuals may be eligible for significant compensation.
To ask questions or obtain more information regarding Risperdal lawsuits, please contact Banville Law by calling (888) 997-3792.
Banville Law is a New York law firm dedicated to assisting plaintiffs in lawsuits involving personal injury, product liability and related legal matters.
165 West End Avenue, #1H
New York, NY 10023
United States (US)
April 29, 2016 – Risperdal Lawsuit Allegations Draw Concern Over Possible Gynecomastia Side Effect
April 29, 2016 – Mother Files Risperdal Lawsuit Claiming Drug Caused Development Of Son’s Gynecomastia
April 29, 2016 – Risperdal Plaintiff Awarded $1.75 Million In Damages
April 28, 2016 – Risperdal Lawsuit Plaintiffs Are Awarded $8 Million After The Death Of A Family Member
April 28, 2016 – Millions Awarded To Plaintiffs In Risperdal Lawsuit Verdicts
April 28, 2016 – Risperdal Lawsuit Trial Draws Attention To Controversial Testimony And Potentially Hidden Study Results
April 27, 2016 – Risperdal Lawsuit Plaintiffs Observe As Millions Paid Out For Risperdal Jury Verdicts
April 27, 2016 – Louisiana Risperdal Lawsuit Plaintiff Claims Drug Caused Son’s Gynecomastia Development
April 27, 2016 – U.S. Supreme Court Shows Favor To Risperdal Lawsuit Plaintiffs
April 26, 2016 – Johnson & Johnson Subsidiary Janssen Pharmaceuticals Loses Third Risperdal Lawsuit